Ioachimescu Adriana G, Goswami Neevedita, Handa Talin, Pappy Adlai, Veledar Emir, Oyesiku Nelson M
Department of Medicine (Endocrinology), Emory School of Medicine, Atlanta, GA 30322, USA.
Department of Neurosurgery, Emory School of Medicine, Atlanta, GA 30322, USA.
J Endocr Soc. 2021 Nov 24;6(1):bvab176. doi: 10.1210/jendso/bvab176. eCollection 2022 Jan 1.
Acromegaly (ACM) and Cushing's disease (CD) are caused by functioning pituitary adenomas secreting growth hormone and ACTH respectively.
To determine the impact of race on presentation and postoperative outcomes in adults with ACM and CD, which has not yet been evaluated.
This is a retrospective study of consecutive patients operated at a large-volume pituitary center. We evaluated (1) racial distribution of patients residing in the metropolitan area (Metro, N = 124) vs 2010 US census data, and(2) presentation and postoperative outcomes in Black vs White for patients from the entire catchment area (N = 241).
For Metro area (32.4% Black population), Black patients represented 16.75% ACM ( = .006) and 29.2% CD ( = .56). Among the total 112 patients with ACM, presentations with headaches or incidentaloma were more common in Black patients (76.9% vs 31% White, = .01). Black patients had a higher prevalence of diabetes (54% vs 16% White, = .005), significantly lower interferon insulin-like growth factor (IGF)-1 deviation from normal ( = .03) and borderline lower median growth hormone levels ( = .09). Mean tumor diameter and proportion of tumors with cavernous sinus invasion were similar. Three-month biochemical remission (46% Black, 55% White, = .76) and long-term IGF-1 control by multimodality therapy (92.3% Black, 80.5% White, = .45) were similar. Among the total 129 patients with CD, Black patients had more hypopituitarism (69% vs 45% White, = .04) and macroadenomas (33% vs 15% White, = .05). At 3 months, remission rate was borderline higher in White (92% vs 78% Black, = 0.08), which was attributed to macroadenomas by logistic regression.
We identified disparities regarding racial distribution, and clinical and biochemical characteristics in ACM, suggesting late or missed diagnosis in Black patients. Large nationwide studies are necessary to confirm our findings.
肢端肥大症(ACM)和库欣病(CD)分别由分泌生长激素和促肾上腺皮质激素(ACTH)的功能性垂体腺瘤引起。
确定种族对成人ACM和CD患者临床表现及术后结局的影响,此前尚未对此进行评估。
这是一项对一家大型垂体中心连续手术患者的回顾性研究。我们评估了(1)大都市地区(市区,N = 124)患者的种族分布与2010年美国人口普查数据的对比,以及(2)整个集水区(N = 241)患者中黑人和白人的临床表现及术后结局。
对于市区(黑人人口占32.4%),黑人患者占ACM患者的16.75%(P = 0.006),占CD患者的29.2%(P = 0.56)。在总共112例ACM患者中,黑人患者出现头痛或意外瘤的情况更为常见(76.9% vs白人31%,P = 0.01)。黑人患者糖尿病患病率更高(54% vs白人16%,P = 0.005),干扰素胰岛素样生长因子(IGF)-1偏离正常水平显著更低(P = 0.03),生长激素中位数略低(P = 0.09)。平均肿瘤直径及海绵窦侵袭性肿瘤的比例相似。三个月时的生化缓解情况(黑人46%,白人55%,P = 0.76)以及多模式治疗的长期IGF-1控制情况(黑人92.3%,白人80.5%,P = 0.45)相似。在总共129例CD患者中,黑人患者垂体功能减退更多见(69% vs白人45%,P = 0.04),大腺瘤更多见(33% vs白人15%,P = 0.05)。三个月时,白人的缓解率略高(92% vs黑人78%,P = 0.08),经逻辑回归分析这归因于大腺瘤。
我们发现了ACM在种族分布、临床和生化特征方面的差异,提示黑人患者存在诊断延迟或漏诊情况。需要开展大规模全国性研究来证实我们的发现。